Dr. Mintz-Hittner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6400 Fannin St
Ste 1800
Houston, TX 77030Phone+1 713-559-5200Fax+1 713-795-0733
Education & Training
- Baylor College of Medicine/Cullen Eye InstituteResidency, Ophthalmology, 1970 - 1974
- Baylor College of MedicineInternship, Transitional Year, 1969 - 1970
- Baylor College of MedicineClass of 1969
Certifications & Licensure
- TX State Medical License 1969 - 2022
- GA State Medical License 2004 - 2019
- NV State Medical License 2011 - 2019
- IA State Medical License 1987 - 1990
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity Start of enrollment: 2008 Mar 01
Publications & Presentations
PubMed
- 2 citationsNeurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trialIra Adams-Chapman, Kristi L. Watterberg, Tracy L. Nolen, Shawn Hirsch, Carol A. Cole
Journal of Perinatology. 2021-03-23 - 23 citationsEffects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial.Dale L. Phelps, Kristi L. Watterberg, Tracy L. Nolen, Carol A. Cole, C. Michael Cotten
JAMA. 2018-10-23 - 73 citationsMedical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurityKathleen A. Kennedy, Helen A. Mintz-Hittner
Journal of AAPOS. 2018-02-01
Professional Memberships
- Fellow
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: